Dementia and Geriatric Cognitive Disorders

Original Research Article

In vivo Quantification of Brain Volumes in Subcortical Vascular Dementia and Alzheimer’s Disease

An MRI-Based Study

Pantel J.a · Schröder J.a · Essig M.b · Jauss M.a · Schneider G.a · Eysenbach K.a · von Kummer R.c · Baudendistel K.b · Schad L.R.b · Knopp M.V.b

Author affiliations

a Section of Geriatric Psychiatry, Department of Psychiatry, University of Heidelberg, b German Cancer Research Institute (DKFZ), Heidelberg, c Department of Neuroradiology, University of Dresden, Germany

Related Articles for ""

Dement Geriatr Cogn Disord 1998;9:309–316

Log in to MyKarger to check if you already have access to this content.


Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!


If you would like to redeem your KAB credit, please log in.


Save over 20% compared to the individual article price.

Learn more

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply

Rental: USD 8.50
Cloud: USD 20.00

Select

Subscribe

  • Access to all articles of the subscribed year(s) guaranteed for 5 years
  • Unlimited re-access via Subscriber Login or MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

Subcription rates


Select
* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview
Abstract of Original Research Article

Published online: October 23, 1998
Issue release date: November – December

Number of Print Pages: 8
Number of Figures: 1
Number of Tables: 2

ISSN: 1420-8008 (Print)
eISSN: 1421-9824 (Online)

For additional information: https://www.karger.com/DEM

Abstract

Quantitative magnetic resonance imaging (MRI) was used to assess global and regional cerebral volumes in patients with a clinical diagnosis of subcortical vascular dementia (VD) and Alzheimer’s disease (AD). Whole brain volume, cerebrospinal fluid volume, volumes of the temporal, frontal and parietal lobes, the cerebellum and the amygdala-hippocampus complex were determined using a personal computer-based software. Seventeen patients with VD, 22 patients with AD and 13 healthy controls were included. Analysis of covariance using age as covariate demonstrated significant mean differences between controls and dementia groups with respect to all morphological parameters. However, apart from the volume of the cerebellum no significant volumetric differences were found between VD and AD. These results indicate that MRI-based volumetry allows differentiation between AD or VD from normal controls and that measurement of cerebellar volume may be of use to separate vascular and degenerative dementia. However, since the distribution of cerebral atrophy in both dementia groups is very similar, it is suggested that the atrophic changes are not specific to the underlying cause but rather reflect the selective vulnerability of neuronal structures.




Related Articles:


References

  1. Tomlinson BE, Hendersen G: Observations on the brains of demented old people; in Terry RD, Gershon S (eds): Neurobiology of Aging. New York, Raven, 1976, pp 88–94.
  2. Cummings JL, Benson DF: Dementia. A Clinical Approach. Boston, Butterworths, 1983.
  3. Miller Fisher C: Binswanger’s encephalopathy: A review: J Neurol 1989;236:65–79.
  4. Erkinjuntti T: The matter of white matter; in Bergener M, Brocklehurst JC, Finkel SI (eds): Health, Aging and Healing. New York, Springer, 1995, pp 83–97.
  5. Erkinjuntti T, Ketonen L, Sulkava R, Vuorialho M, Palo J: CT in the differential diagnosis between Alzheimer’s disease and vascular dementia. Acta Neurol Scand 1987;75:262–270.
  6. Aharon-Peretz J, Cummings JL, Hill MA: Vascular dementia and dementia of the Alzheimer type. Cognition, ventricular size, and leuko-araiosis. Arch Neurol 1988;45:719–721.
    External Resources
  7. Charletta D, Gorelick PB, Dollear TJ, Freels S, Harris Y: CT and MRI findings among African-Americans with Alzheimer’s disease, vascular dementia and stroke without dementia. Neurology 1995;45:1456–1461.
  8. Schmidt R: Comparison of magnetic resonance imaging in Alzheimer’s disease, vascular dementia and normal aging. Eur Neurol 1992;32:164–169.
  9. Jack CR, Peterson RCA, O’Brien PC, Tangelos EG: MR-based hippocampal volumetry in the diagnosis of Alzheimer’s disease. Neurology 1992;42:183–188.
  10. Scheltens P, Leys DL, Barkhof F, Huglo D, Weinstein HC, Vermesch P, Kuiper M, Steinling M, Wolters EC, Valk J: Atrophy of medial temporal lobes on MRI in ‘probable’ Alzheimer’s disease and normal ageing: Diagnostic value and neuropsychological correlates. J Neurol Neurosurg Psychiatry 1992;5:967–972.
  11. Killiany RJ, Moss MB, Alber MS, Sandor T, Tieman J, Jolesz F: Temporal lobe regions on magnetic resonance imaging identify patients with early Alzheimer’s disease. Arch Neurol 1993;50:949–954.
  12. Murphy DGM, DeCarli CD, Daly E, Gillette JA, McIntosh AR, Haxby D, Teichberg D, Schapiro MB, Rapoport SI, Horwitz B: Volumetric magnetic resonance imaging in men with dementia of the Alzheimer type: Correlations with the disease severity. Biol Psychiatry 1993;34:612–621.
  13. Cuenod CA, Denys A, Michot JL, Jehenson P, Forette F, Kaplan D, Syrota A, Boller F: Amygdala atrophy in Alzheimer’s disease. Arch Neurol 1993;50:941–945.
  14. Lehericy S, Baulac M, Chiras J, Piérot L, Martin N, Pillon B, Deweer B, Dubois B, Marsault C: Amygdalohippocampal MR volume measurements in the early stages of Alzheimer disease. AJNR 1994;15:929–937.
  15. Pantel J, Schröder J, Schad LR, Friedlinger M, Knopp MV, Schmitt R, Geissler M, Blüml S, Essig M, Sauer H: Quantitative magnetic resonance imaging and neuropsychological functions in dementia of the Alzheimer type. Psychol Med 1997;27:221–229.
  16. Soininen HS, Partanen K, Pitkänen A, Vainio P, Hänninen T, Hallikainen M, Koivisto K, Riekinen PJ: Volumetric MRI analysis of the amygdala and the hippocampus in subjects with age-associated memory impairment. Neurology 1994;44:1660–1668.
  17. O’Brien JT, Desmond P, Ames D, Schweitzer I, Tuckwell V, Tress B: The differentiation of depression from dementia by temporal lobe magnetic resonance imaging. Psychol Med 1994;24:633–640.
  18. Braak H, Braak E, Bohl J: Staging of Alzheimer-related cortical destruction. Eur Neurol 1993;33:403–408.
  19. Babikian V, Ropper AH: Binswanger’s disease: A review. Stroke 1987;18:2–12.
    External Resources
  20. Horn R, Ostertun B, Fric M, Solymosi L, Steudel A, Möller HJ: Atrophy of hippocampus in patients with Alzheimer’s disease and other diseases with memory impairment. Dementia 1996;7:182–186.
  21. Folstein MF, Folstein SE, McHugh PR: ‘Mini mental state’: A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189–198.
  22. Reisberg B, Ferris SH, De Leon MJ, Crook T: The global deterioration scale (GDS): An instrument for the assessment of primary degenerative dementia (PDD). Am J Psychiatry 1982;139:1136–1139.
  23. Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, Amaducci L, Orgogozo JM, Brun A, et al: Vascular dementia: Diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993;43:250–260.
  24. Loeb C, Gandolfo C: Diagnostic evaluation of degenerative and vascular dementia. Stroke 1983;14:399–401.
    External Resources
  25. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer’s disease: Report of the NINCDS-ADRDA work group under the auspices of department of health and human services task force on Alzheimer’s disease. Neurology 1984;34:939–965.
  26. Friedlinger M, Schad LR, Blüml S, Tritsch B, Lorenz WJ: Rapid automatic brain volumetry on the basis of multispectral 3D MR imaging data on personal computers. Comput Med Imaging Graph 1995;19(2):185–205.
  27. Blüml S, Schad LR, Betsch B, Knopp M, Sauer H, Lorenz WJ: Segmentation and determination of brain compartment volumes using 3D gradient echo sequences; in Society of Magnetic Resonance Imaging in Medicine, Works in Progress. Berlin, SMRM, 1992, p 4263.
  28. SAS-Institute; Inc. SAS-Base, SAS-Statistics. Cary, SAS-Graph, 1990.
  29. Mathalon DH, Sullivan EV, Rawles JM, Pfefferbaum A: Correction for head size in brain-imaging measurements. Psychiatry Res Neuroimaging 1993;50:121–139.
    External Resources
  30. Pullicino P, Benedict RHB, Capruso DX, Vella N, Withiam-Leitch S, Kwen PL: Neuroimaging criteria for vascular dementia. Arch Neurol 1996;53:723–728.
  31. Hershey LA, Modic MT, Greenough PG, Jaffe DF: Magnetic resonance imaging in vascular dementia. Neurology 1987;37:29–36.
    External Resources
  32. Liu CK, Miller BL, Cummings JL, Mehringer CM, Goldberg MA, Howng SL, Benson DF: A quantitative MRI study of vascular dementia. Neurology 1992;42:138–143.
  33. Ball MJ: Topographic distribution of neurofibrillary tangles and granulovacuolar degeneration in hippocampal cortex of aging and demented studies: A quantitative study. Neuropathologica 1978;42:73–80.
    External Resources
  34. Ball MJ, Fisman M, Hachinski V, et al: A new definition of Alzheimer’s disease: A hippocampal dementia. Lancet 1985;333:14–16.
  35. Hyman BT, Van Hoesen GW, Damasio AR: Memory-related neural systems in Alzheimer’s disease: An anatomic study. Neurology 1990;40:1721–1730.
  36. O’Brien JT: Is hippocampal atrophy on magnetic resonance imaging a marker for Alzheimer’s disease? Int J Geriatr Psychiatry 1995;10:431–435.
  37. Laakso MP, Partanen K, Riekkinen P, Lehtovirta M, Helkala EL, Hallikainen M, Hauninen T, Vainio P, Soininen H: Hippocampal volumes in Alzheimer’s disease, Parkinson’s disease with and without dementia, and in vascular dementia. Neurology 1996;46:678–681.
  38. Frisoni BF, Trabucchi M, Beltramello A: Hippocampal atrophy measurement in Alzheimer’s disease. Int J Geriatr Psychiatry 1996;11:81–83.
    External Resources
  39. Ohnishi T, Hoshi H, Nagamachi S, Jinouchi S, Flores LG, Futami S, Watanabe K: High resolution SPECT to assess hippocampal perfusion in neuropsychiatric diseases. J Nucl Med 1995;36:1163–1169.
  40. Pantoni L, Garcia JH, Brown GG: Vascular pathology in three cases of progressive cognitive deterioration. J Neurol Sci 1996;135:131–139.
  41. Olsson Y, Brun A, Englund E: Fundamental pathological lesions in vascular dementia. Acta Neurol Scand 1996;168(suppl):31–38.
  42. Cervos-Navarro J, Diemer NH: Selective vulnerability in brain hypoxia. Crit Rev Neurobiol 1991;6:149–182.
  43. De la Torre JC, Fortin T, Park GAS, Butler KS, Kozlowski P, Pappas BA, de Soccerraz H, Saunders JK, Richard MT: Chronic cerebrovascular insufficiency induces dementia-like deficits in aged rats. Brain Res 1992;582:186–195.
  44. Kuroiwa T, Bonnekoh P, Hossmann KA: Laser doppler flowmetry in CA1 sector of hippocampus and cortex after transient forebrain ischemia in gerbils. Stroke 1992;23:1349–1354.
  45. Barclay LL, Brady PA: Cerebellar atrophy as a CT marker for mixed dementia. Biol Psychiatry 1992;31:520–524.
  46. Chan S, Kartha K, Yoon SS, Desmond DW, Hilal SK: Multifocal hypointense cerebral lesions on gradient-echo MR are associated with chronic hypertension. Am J Neuroradiol 1996;17:1821–1827.
    External Resources
  47. Kushner M, Tobin M, Alavi A, Chawluk J, Rosen M, Fazekas F, Alavi J, Reirich M: Cerebellar glucose consumption in normal and pathologic states using fluorine-FDG and PET. J Nucl Med 1987;28:1667–1670.
    External Resources
  48. Mielke R, Herholz K, Grond M, Kessler J, Heiss WD: Severity of vascular dementia is related to volume of metabolically impaired tissue. Arch Neurol 1992;49:909–913.
  49. Braak H, Braak E, Bohl J, Lang W: Alzheimer’s disease: amyloid plaques in the cerebellum. J Neurol Sci 1989;93:277–287.
  50. Lopez OL, Larumbe MR, Becker JT, Rezek D, Rosen J, Klunk W, DeKosky ST: Reliability of NINDS-AIREN clinical criteria for the diagnosis of vascular dementia. Neurology 1994;44:1240–1245.
  51. Wetterling T, Kanitz RD, Borgis KJ: Comparison of different diagnostic criteria for vascular dementia (ADDTC, DSM-IV, ICD 10, NINDS-AIREN). Stroke 1996;27:30–36.
  52. Emery VOB, Gillie EX, Ramdev P: Spectrum of vascular dementia and the interface with Alzheimer’s disease; in Nicolini M, Zatta PF, Corain B (eds): Alzheimer’s Disease and Related Disorders. Advances in Bioscience. Oxford, Pergamon, 1993, vol 87, pp 13–16.
  53. Gold G, Giannakopoulos P, Montes-Paixao C, Herrmann FR, Mulligan R, Michel JP, Bouras C: Sensitivity and specificity of newly proposed clinical criteria for possible vascular dementia. Neurology 1997;49:690–694.

Article / Publication Details

First-Page Preview
Abstract of Original Research Article

Published online: October 23, 1998
Issue release date: November – December

Number of Print Pages: 8
Number of Figures: 1
Number of Tables: 2

ISSN: 1420-8008 (Print)
eISSN: 1421-9824 (Online)

For additional information: https://www.karger.com/DEM


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
TOP